Nirmatrelvir-ritonavir effective for outpatient treatment of COVID-19
Jun 06, 2023
The combo reduces the 30-day risk for hospitalization and death, whereas only death was reduced in association with molnupiravir.
Researchers developing microneedle technology for painless vaccinations
By
Ryner Lai
May 11, 2023
British researchers say they are developing microneedle technology for vaccine delivery, potentially eliminating the need for painful vaccine injections.
Pegylated interferon lambda effective in preventing severe COVID-19
Feb 09, 2023
The incidence of hospitalization or emergency department visit was lower for those receiving interferon versus placebo.
16.8 million undiagnosed COVID-19 cases in first six months in U.S.
Jun 30, 2021
The overall weighted undiagnosed seropositivity estimate was 4.6%, with estimates ranging from 1.1 to 14.2% by subgroup.
Disparities in COVID-19 vaccination identified among healthcare employees
Jun 16, 2021
Vaccination was least likely among clinical nurses, support staff and workers at skilled nursing and rehabilitation facilities.
Expansion will proceed, despite COVID-19 challenges
By
Amy Novotney
Jul 30, 2020
Investment Banking firm HJ Sims recently announced the successful closure of $6.6 million in financing for pre-development capital toward the pursuit of an expansion at the Raleigh, NC-based life plan...
AI plus wearable sensor may detect presymptomatic COVID-19
Jun 23, 2022
AI algorithm interpreting data from a wearable sensor bracelet that monitors changes in physiologic parameters might allow early detection.
COVID-19 hospitalization rates higher in unvaccinated during omicron
Sep 14, 2022
Hospitalization rates were 2.5 times higher for vaccinated patients without booster versus those with a booster.
Just 20 states reached Biden’s July 4 vaccination goal
Jul 06, 2021
Parts of the South, Southwest and Midwest starting to see surges, particularly Florida, with about 17% of all new cases reported there.
Early use of COVID-19 convalescent plasma cuts hospitalization risk
Apr 01, 2022
Administration of convalescent plasma within nine days after symptom onset can reduce the risk of COVID-19-linked hospitalization.